Dossier Evaluation status

Dossier Evaluation status

Dossier Evaluation status

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

You can access the disseminated registration dossier, available in the ‘Registered substances’ section of ECHA’s website, by clicking on the magnifying glass icon. Except when confidentiality is claimed on the substance identifiers, the adopted decision is directly linked to the disseminated dossier.

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent data on a substance is available in the ‘Registered substances’ section of ECHA’s website; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
  • The information in the disseminated registration dossier is obtained from all registration dossiers which are part of the joint submission of a substance, including the names of the registrants, unless claimed confidential.
Last updated 24 March 2023. Database contains 3896 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
293-049-4
91051-01-3
CCH
Targeted
Concluded
20-Aug-2013
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C16-C18 alkyl carboxylic acid sodium salt and SDA Reporting Number: 19-006-04.
270-299-2
68424-38-4
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
293-014-3
91032-08-5
TPE
Testing Proposal
Concluded
11-Jan-2016
26-Nov-2022
View
Details
293-014-3
91032-08-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
306-084-8
95912-88-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
285-547-5
85116-93-4
CCH
Targeted
Concluded
13-Dec-2013
26-Nov-2022
View
Details
285-547-5
85116-93-4
CCH
Targeted
Concluded
26-Nov-2022
View
Details
292-883-6
91002-07-2
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
306-232-1
96690-38-9
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
931-209-3
1337540-53-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
931-209-3
1337540-53-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
606-712-3
211450-54-3
TPE
Testing Proposal
Concluded
27-May-2015
26-Nov-2022
View
Details
605-143-8
158318-67-3
TPE
Testing Proposal
Concluded
11-Mar-2015
26-Nov-2022
View
Details
The complex residuum from the distillation of the methyl ester of C16-18 and C18-unsatd. fatty acids. It consists primarily of trialkyl glycerides and undistilled methyl ester of the fatty acids.
271-692-1
68604-41-1
CCH
Targeted
Concluded
30-Jun-2015
26-Nov-2022
View
Details
The complex residuum from the distillation of the methyl ester of C16-18 and C18-unsatd. fatty acids. It consists primarily of trialkyl glycerides and undistilled methyl ester of the fatty acids.
271-692-1
68604-41-1
CCH
Targeted
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C16-C18 and C18 unsaturated alkyl carboxylic acid methyl ester and SDA Reporting Number: 11-010-00.
267-015-4
67762-38-3
CCH
Targeted
Concluded
26-Nov-2022
View
Details
285-206-0
85049-36-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
285-206-0
85049-36-1
CCH
Targeted
Concluded
24-Apr-2012
26-Nov-2022
View
Details
285-203-4
85049-34-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
615-494-9
71808-39-4
TPE
Testing Proposal
Concluded
25-Jul-2013
26-Nov-2022
View
Details
806-509-1
1393571-42-0
TPE
Testing Proposal
Concluded
16-Jun-2015
26-Nov-2022
View
Details
939-017-1
1469982-94-2
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
441-620-5
-
TPE
Testing Proposal
Follow-up
08-Aug-2019
26-Nov-2022
Details
273-295-9
68955-98-6
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
273-295-9
68955-98-6
TPE
Testing Proposal
Concluded
25-Jul-2013
26-Nov-2022
View
Details
285-207-6
85049-37-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
947-666-7
-
CCH
Comprehensive
Follow-up
24-Nov-2021
26-Nov-2022
View
Details
943-011-4
-
CCH
Comprehensive
Follow-up
14-Apr-2021
26-Nov-2022
View
Details
939-066-9
308065-29-4
CCH
Comprehensive
Concluded
04-Nov-2016
26-Nov-2022
View
Details
701-023-5
-
CCH
Targeted
Concluded
13-Dec-2013
26-Nov-2022
View
Details
701-023-5
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
931-203-0
1335202-88-4
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C16 and C18 unsaturated trialkyl carboxylic acid trimethylolpropane triester and SDA Reporting Number: 09-015-00.
270-287-7
68424-27-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C16 and C18 unsaturated trialkyl carboxylic acid trimethylolpropane triester and SDA Reporting Number: 09-015-00.
270-287-7
68424-27-1
CCH
Targeted
Concluded
13-Dec-2013
26-Nov-2022
View
Details
600-687-2
105839-18-7
TPE
Testing Proposal
Concluded
30-May-2017
26-Nov-2022
View
Details
701-259-9
-
CCH
Comprehensive
Concluded
20-Aug-2020
26-Nov-2022
View
Details
701-259-9
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
921-836-0
1190402-12-0
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
305-962-8
95370-96-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid zinc salt and SDA Reporting Number: 04-006-09.
266-936-9
67701-12-6
CCH
Targeted
Concluded
20-Aug-2013
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid methyl ester and SDA Reporting Number: 04-010-00.
267-007-0
67762-26-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid methyl ester and SDA Reporting Number: 04-010-00.
267-007-0
67762-26-9
CCH
Targeted
Concluded
09-Dec-2015
26-Nov-2022
View
Details
284-864-6
84988-75-0
CCH
Comprehensive
Follow-up
14-Apr-2021
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid and SDA Reporting Number: 04-005-00.
266-930-6
67701-06-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
292-811-3
91001-42-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
This substance is identified by SDA Substance Name: C12-C18 alkyl carboxylic acid and SDA Reporting Number: 16-005-00.
266-925-9
67701-01-3
CCH
Targeted
Concluded
25-Nov-2014
26-Nov-2022
View
Details
942-523-5
2156594-77-1
TPE
Testing Proposal
Follow-up
11-Mar-2020
26-Nov-2022
View
Details
942-523-5
2156594-77-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
942-523-5
2156594-77-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
285-200-8
85049-31-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
629-765-4
1226892-44-9
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
629-765-4
1226892-44-9
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
629-725-6
1226892-45-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
629-725-6
1226892-45-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
629-725-6
1226892-45-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
629-732-4
1224966-13-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
629-732-4
1224966-13-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
939-538-4
1471313-87-7
TPE
Testing Proposal
Concluded
23-Feb-2015
26-Nov-2022
View
Details
800-253-4
1419212-73-9
TPE
Testing Proposal
Concluded
20-Sep-2016
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly higher than C25.
265-110-5
64742-10-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly higher than C25.
265-110-5
64742-10-5
TPE
Testing Proposal
Follow-up
04-May-2020
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.
265-103-7
64742-04-7
CCH
Targeted
Concluded
18-Aug-2014
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained by solvent extraction of a vacuum-deasphalted residue. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C30. This stream contains more than 5 wt. % of 4- to 6-membered condensed ring aromatic hydrocarbons.
295-332-8
91995-70-9
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained by solvent extraction of a vacuum-deasphalted residue. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C30. This stream contains more than 5 wt. % of 4- to 6-membered condensed ring aromatic hydrocarbons.
295-332-8
91995-70-9
TPE
Testing Proposal
Follow-up
04-May-2020
26-Nov-2022
View
Details
A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100°C to 200°C (212°F to 392°F).
295-331-2
91995-68-5
CCH
Targeted
Concluded
18-Aug-2014
26-Nov-2022
View
Details
309-867-2
101316-62-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
231-403-1
7534-94-3
CCH
Comprehensive
Concluded
19-Jul-2016
26-Nov-2022
View
Details
231-403-1
7534-94-3
CCH
Targeted
Concluded
26-Nov-2022
View
Details
204-727-6
125-12-2
CCH
Comprehensive
Concluded
07-Mar-2018
26-Nov-2022
View
Details
226-029-0
5232-99-5
TPE
Testing Proposal
Concluded
02-Sep-2020
26-Nov-2022
View
Details
220-552-8
2809-21-4
CCH
Targeted
Concluded
26-Nov-2022
View
Details
216-223-3
1530-32-1
CCH
Comprehensive
Follow-up
18-Aug-2022
26-Nov-2022
View
Details
216-223-3
1530-32-1
CCH
Targeted
Follow-up
20-Nov-2018
26-Nov-2022
View
Details
238-914-9
14852-17-6
TPE
Testing Proposal
Concluded
07-Dec-2020
26-Nov-2022
View
Details
(>1 <8.5 mol PO)
500-035-6
25214-63-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
1 - 4.8 moles ethoxylated and 1 - 8.5 moles propoxylated
500-047-1
26316-40-5
CCH
Comprehensive
Concluded
26-Aug-2014
26-Nov-2022
View
Details
203-468-6
107-15-3
CCH
Comprehensive
Concluded
07-Oct-2014
26-Nov-2022
View
Details
253-039-2
36443-68-2
CCH
Comprehensive
Concluded
05-Dec-2017
26-Nov-2022
View
Details
931-746-3
-
CCH
Targeted
Concluded
10-May-2012
26-Nov-2022
View
Details
931-746-3
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
931-746-3
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
211-014-3
627-83-8
CCH
Comprehensive
Follow-up
14-Apr-2021
26-Nov-2022
View
Details
211-063-0
628-96-6
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
211-063-0
628-96-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
211-063-0
628-96-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
211-063-0
628-96-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
202-617-2
97-90-5
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
211-077-7
629-15-2
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
202-338-6
94-49-5
TPE
Testing Proposal
Concluded
28-May-2019
26-Nov-2022
View
Details
204-653-4
123-81-9
CCH
Comprehensive
Follow-up
05-Aug-2020
26-Nov-2022
View
Details
203-881-1
111-55-7
CCH
Comprehensive
Concluded
15-Dec-2016
26-Nov-2022
View
Details
202-510-0
96-49-1
CCH
Targeted
Concluded
26-Nov-2022
View
Details
202-510-0
96-49-1
CCH
Comprehensive
Concluded
18-Dec-2014
26-Nov-2022
View
Details
202-510-0
96-49-1
CCH
Comprehensive
Concluded
18-Dec-2014
26-Nov-2022
View
Details
202-510-0
96-49-1
CCH
Targeted
Concluded
18-Dec-2014
26-Nov-2022
View
Details
251-073-2
32509-66-3
TPE
Testing Proposal
Concluded
17-Feb-2016
26-Nov-2022
View
Details
200-815-3
74-85-1
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
200-815-3
74-85-1
CCH
Comprehensive
Concluded
16-Apr-2013
26-Nov-2022
View
Details
209-940-8
598-56-1
CCH
Targeted
Concluded
26-Nov-2022
View
Details
209-940-8
598-56-1
CCH
Comprehensive
Follow-up
23-Aug-2017
26-Nov-2022
View
Details
209-940-8
598-56-1
TPE
Testing Proposal
Concluded
26-Jan-2012
26-Nov-2022
View
Details
230-392-0
7087-68-5
CCH
Comprehensive
Concluded
22-Nov-2018
26-Nov-2022
View
Details
230-392-0
7087-68-5
TPE
Testing Proposal
Concluded
24-Mar-2015
26-Nov-2022
View
Details
216-835-0
1678-91-7
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
202-849-4
100-41-4
CCH
Targeted
Concluded
26-Nov-2022
View
Details
202-849-4
100-41-4
CCH
Targeted
Concluded
26-Nov-2022
View
Details
282-810-6
84434-11-7
TPE
Testing Proposal
Concluded
10-Dec-2015
26-Nov-2022
View
Details
433-480-9
623-53-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
433-480-9
623-53-0
TPE
Testing Proposal
Follow-up
13-Dec-2018
26-Nov-2022
View
Details
202-597-5
97-63-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
202-597-5
97-63-2
CCH
Comprehensive
Follow-up
20-Apr-2021
26-Nov-2022
View
Details
202-284-3
93-89-0
CCH
Comprehensive
Concluded
21-Jan-2021
26-Nov-2022
View
Details
205-438-8
140-88-5
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
205-438-8
140-88-5
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
205-500-4
141-78-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
205-500-4
141-78-6
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
268-500-3
68109-88-6
CCH
Targeted
Concluded
26-Nov-2022
View
Details
204-399-4
120-47-8
CCH
Comprehensive
Follow-up
16-Jul-2018
26-Nov-2022
View
Details
204-399-4
120-47-8
CCH
Comprehensive
Ongoing
26-Nov-2022
View
Details
212-112-9
763-69-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
212-112-9
763-69-9
CCH
Targeted
Concluded
28-Feb-2014
26-Nov-2022
View
Details
404-740-9
115895-09-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
404-740-9
115895-09-5
TPE
Testing Proposal
Concluded
14-Nov-2012
26-Nov-2022
View
Details
404-740-9
115895-09-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
231-225-4
7452-79-1
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
230-391-5
7085-85-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
230-391-5
7085-85-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
230-391-5
7085-85-0
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
211-694-1
687-47-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
211-694-1
687-47-8
CCH
Comprehensive
Concluded
22-Aug-2014
26-Nov-2022
View
Details
642-362-8
1190630-03-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
434-800-1
121776-33-8
CCH
Comprehensive
Concluded
25-Apr-2018
26-Nov-2022
View
Details
619-372-6
98730-04-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
921-042-4
24085-06-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
310-290-3
161907-80-8
CCH
Targeted
Concluded
23-Nov-2011
26-Nov-2022
View
Details
310-290-3
161907-80-8
TPE
Testing Proposal
Concluded
30-Jan-2013
26-Nov-2022
View
Details
A complex residuum from the fractionation of the reaction products of 2-aminoethanol with ammonia to remove piperazine. It may contain such compounds as 2-[(2-aminoethyl)amino]ethanol, (aminoethyl)piperazine, (hydroxyethyl)piperazine.
272-729-4
68910-05-4
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
A complex residuum from the fractionation of the reaction products of 2-aminoethanol with ammonia to remove piperazine. It may contain such compounds as 2-[(2-aminoethyl)amino]ethanol, (aminoethyl)piperazine, (hydroxyethyl)piperazine.
272-729-4
68910-05-4
CCH
Targeted
Concluded
10-Nov-2011
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
CCH
Targeted
Concluded
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
TPE
Testing Proposal
Concluded
29-Mar-2012
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
CCH
Comprehensive
Follow-up
31-Jan-2017
26-Nov-2022
View
Details
The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
272-712-1
68909-77-3
CCH
Targeted
Concluded
26-Nov-2022
View
Details
276-014-8
71786-60-2
TPE
Testing Proposal
Concluded
07-Apr-2017
26-Nov-2022
View
Details
276-014-8
71786-60-2
TPE
Testing Proposal
Follow-up
07-Feb-2020
26-Nov-2022
View
Details
308-208-6
97925-95-6
CCH
Targeted
Concluded
25-Nov-2014
26-Nov-2022
View
Details
308-208-6
97925-95-6
TPE
Testing Proposal
Concluded
13-Jun-2012
26-Nov-2022
View
Details
308-208-6
97925-95-6
TPE
Testing Proposal
Concluded
30-Sep-2015
26-Nov-2022
View
Details
200-578-6
64-17-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
200-837-3
75-08-1
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
263-174-9
61791-42-2
CCH
Comprehensive
Concluded
22-Mar-2018
26-Nov-2022
View
Details
203-473-3
107-21-1
CCH
Targeted
Concluded
26-Nov-2022
View
Details
203-473-3
107-21-1
CCH
Targeted
Concluded
26-Nov-2022
View
Details
203-473-3
107-21-1
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
1 - 4.5 moles propoxylated
500-078-0
31923-84-9
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
1 - 4.5 moles propoxylated
500-078-0
31923-84-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
1 - 4.5 moles propoxylated
500-078-0
31923-84-9
TPE
Testing Proposal
Concluded
04-Jul-2019
26-Nov-2022
View
Details
620-174-7
1079184-43-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
620-174-7
1079184-43-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
620-174-7
1079184-43-2
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
620-174-7
1079184-43-2
CCH
Comprehensive
Concluded
27-Apr-2018
26-Nov-2022
View
Details
947-975-7
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
947-975-7
-
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
923-900-3
-
CCH
Comprehensive
Follow-up
03-Feb-2020
26-Nov-2022
View
Details
701-362-9
-
TPE
Testing Proposal
Concluded
25-Oct-2016
26-Nov-2022
View
Details
701-362-9
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
700-064-6
1059667-42-3
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
946-253-9
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
603-467-4
13127-18-9
CCH
Targeted
Concluded
26-Nov-2022
View
Details
212-073-8
759-94-4
CCH
Comprehensive
Concluded
06-Aug-2020
26-Nov-2022
View
Details
937-130-0
-
CCH
Targeted
Concluded
26-Nov-2022
View
Details
200-449-4
60-00-4
TPE
Testing Proposal
Concluded
13-Nov-2012
26-Nov-2022
View
Details
The dust generated during the charging, operation, and tapping of a steelmaking furnace and from steel conditioning, including that which is recovered through the use of pollution abatement equipment. Composed primarily of iron oxides. May contain varying amounts of other metallic oxides and trace compounds.
266-005-7
65996-72-7
TPE
Testing Proposal
Concluded
04-Jul-2012
26-Nov-2022
View
Details
442-790-3
-
TPE
Testing Proposal
Concluded
12-Jul-2011
26-Nov-2022
View
Details
203-943-8
112-18-5
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
205-570-6
142-90-5
CCH
Targeted
Concluded
26-Nov-2022
View
Details
218-463-4
2156-97-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details
218-463-4
2156-97-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
218-463-4
2156-97-0
CCH
Comprehensive
Concluded
27-Sep-2017
26-Nov-2022
View
Details
264-867-9
64396-12-9
TPE
Testing Proposal
Follow-up
04-Jun-2021
26-Nov-2022
View
Details
A complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isotridecanal from the hydroformylation of dodecene. It consists predominantly of C10-12 olefins and paraffins and C13 alcohols and aldehydes and boils in the range of approximately 160°C to 253°C (320°F to 487°F).
271-240-3
68526-92-1
TPE
Testing Proposal
Concluded
07-May-2015
26-Nov-2022
View
Details
A complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isotridecanal from the hydroformylation of dodecene. It consists predominantly of C10-12 olefins and paraffins and C13 alcohols and aldehydes and boils in the range of approximately 160°C to 253°C (320°F to 487°F).
271-240-3
68526-92-1
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
A complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isotridecanal from the hydroformylation of dodecene. It consists predominantly of C13-14 primary aliphatic alcohols, C22-28 dimer alcohols, C26 acetals and esters, and C>10 acid sodium salts and boils in the range of approximately 250°C to 450°C (482°F to 842°F).
271-239-8
68526-91-0
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
246-922-9
25378-22-7
CCH
Targeted
Concluded
26-Nov-2022
View
Details
246-922-9
25378-22-7
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
700-071-4
932742-30-8
TPE
Testing Proposal
Concluded
28-Jun-2013
26-Nov-2022
View
Details
700-071-4
932742-30-8
CCH
Targeted
Concluded
26-Nov-2022
View
Details
700-067-2
931419-77-1
CCH
Targeted
Concluded
13-Oct-2011
26-Nov-2022
View
Details
468-880-2
102985-93-3
TPE
Testing Proposal
Concluded
19-Dec-2014
26-Nov-2022
View
Details
479-930-8
613222-52-9
TPE
Testing Proposal
Concluded
30-Apr-2015
26-Nov-2022
View
Details
211-746-3
693-23-2
CCH
Comprehensive
Concluded
26-Nov-2022
View
Details
211-746-3
693-23-2
CCH
Targeted
Concluded
26-Nov-2022
View
Details
923-400-5
-
CCH
Targeted
Concluded
05-Jan-2016
26-Nov-2022
View
Details
923-400-5
-
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
213-424-8
947-04-6
CCH
Comprehensive
Concluded
09-Oct-2015
26-Nov-2022
View
Details
203-967-9
112-40-3
CCH
Targeted
Concluded
01-Aug-2011
26-Nov-2022
View
Details
203-967-9
112-40-3
TPE
Testing Proposal
Concluded
26-Nov-2022
View
Details
211-932-4
713-95-1
CCH
Comprehensive
Ongoing
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-002-6
9002-92-0
CCH
Comprehensive
Follow-up
30-Jun-2020
26-Nov-2022
View
Details
1 - 2.5 moles ethoxylated
500-002-6
9002-92-0
CCH
Targeted
Concluded
26-Nov-2022
View
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.